Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 5 - Project Integrum News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Project Integrum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Project Integrum Today - Breaking & Trending Today
Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene
/PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") reached an agreement with BeiGene (Beijing) Co., Ltd. ("BeiGene") (NASDAQ: BGNE;...
Source: prnewswire.com
Biocytogen Enters Agreement With CtM Bio to Co-develop TCR-Mimic Antibody-Based Multi-Specific T cell Engagers
BEIJING and SHANGHAI, April 18, 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (hereafter referred to as "Biocytogen") announced a collaboration agreement with CtM Biotech
Source: finanznachrichten.de
Biocytogen Subsidiary Eucure Biopharma Completes First Patient Dosing for Phase I Clinical Trial of YH003 (Anti-CD40 mAb) Triple Combination Therapy
BEIJING, April 6, 2022 /PRNewswire/ -- Biocytogen subsidiary Eucure Biopharma announced the first patient dosing for a phase I clinical trial (No....
Source: businessinsider.com
China's Biocytogen expands global footprint with opening of innovation centre in Germany
To form new collaborations with European partners
Source: biospectrumasia.com